C Hall Selected Research

N-terminal proatrial natriuretic peptide

7/2002	Prognostic value of two-dimensional echocardiography and N-terminal proatrial natriuretic peptide following an acute myocardial infarction. Assessment of baseline values (2-7 days) and changes at 3 months in patients with a preserved systolic function.
12/2001	Changes in vasoconstrictive hormones, natriuretic peptides, and left ventricular remodeling soon after anterior myocardial infarction.
6/2001	Effects of dose-intensive chemotherapy and radiotherapy on serum n-terminal proatrial natriuretic peptide in high-risk breast cancer patients.
2/2001	Fluid balance in patients with chronic renal failure assessed with N-terminal proatrial natriuretic peptide, atrial natriuretic peptide and ultrasonography.
9/2000	N-terminal proatrial natriuretic peptide and prognosis in patients with heart failure and preserved systolic function.
8/2000	Postexercise ischemia is associated with increased neuropeptide Y in patients with coronary artery disease.
6/2000	Cardiac natriuretic peptides and continuously monitored atrial pressures during chronic rapid pacing in pigs.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

C Hall Research Topics

Disease

15	Heart Failure 10/2006 - 04/2000
7	Neoplasms (Cancer) 01/2019 - 04/2001
5	Myocardial Infarction 07/2002 - 01/2001
4	Pain (Aches) 01/2021 - 11/2000
3	Breast Neoplasms (Breast Cancer) 12/2019 - 04/2001
3	Rheumatoid Arthritis 04/2016 - 05/2008
3	Heart Diseases (Heart Disease) 10/2008 - 02/2001
3	Hemorrhage 01/2007 - 02/2001
3	Left Ventricular Dysfunction 02/2001 - 09/2000
2	COVID-19 11/2021 - 01/2021
2	Necrosis 01/2017 - 10/2013
2	Vasculitis (Vasculitides) 12/2009 - 07/2009
2	Hemorrhagic Shock 01/2007 - 01/2007
2	Infarction (Infarctions) 07/2002 - 01/2001
2	Ventricular Remodeling 12/2001 - 01/2001
2	Neuroblastoma 11/2001 - 07/2001
2	Colorectal Neoplasms (Colorectal Cancer) 09/2001 - 05/2001
2	Prostatic Neoplasms (Prostate Cancer) 04/2001 - 02/2001
2	Migraine Disorders (Migraine) 11/2000 - 11/2000
2	Headache (Headaches) 11/2000 - 11/2000
1	Obesity 09/2020
1	Malignant Mesothelioma 01/2019
1	Hypoxia (Hypoxemia) 07/2018
1	Fibrosis (Cirrhosis) 01/2018
1	Infections 01/2018
1	Colonic Neoplasms (Colon Cancer) 07/2017
1	Rectal Neoplasms (Rectal Cancer) 07/2017
1	Arthritis (Polyarthritis) 01/2017
1	Dentin Sensitivity 01/2017
1	Wounds and Injuries (Trauma) 01/2017
1	Osteoarthritis 01/2017
1	Multiple Trauma (Multiple Injuries) 01/2017
1	Tooth Wear 01/2017
1	Hypothermia 10/2013
1	Vascular Diseases (Vascular Disease) 10/2013
1	Chronic Renal Insufficiency 10/2013
1	Residual Neoplasm 02/2013
1	Hyperinsulinism (Hyperinsulinemia) 01/2013
1	Glucose Intolerance 01/2013
1	Chronic Cough 05/2011
1	Cough 05/2011
1	Gastroesophageal Reflux (GERD) 05/2011
1	Rectovaginal Fistula 03/2011
1	Uterine Prolapse (Vaginal Prolapse) 03/2011

Drug/Important Bio-Agent (IBA)

10	Natriuretic PeptidesIBA 10/2006 - 04/2000
8	Brain Natriuretic Peptide (Natrecor)FDA Link 10/2008 - 06/2000
7	N-terminal proatrial natriuretic peptideIBA 07/2002 - 06/2000
6	Atrial Natriuretic Factor (ANF)IBA 10/2001 - 06/2000
5	Peptides (Polypeptides)IBA 12/2001 - 04/2000
4	Neurotransmitter Agents (Neurotransmitter)IBA 08/2003 - 01/2001
3	Proteins (Proteins, Gene)FDA Link 01/2021 - 09/2001
3	Oxygen (Dioxygen)IBA 07/2018 - 01/2007
3	Pharmaceutical PreparationsIBA 04/2016 - 11/2000
3	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 08/2003 - 01/2001
3	Monoclonal AntibodiesIBA 06/2001 - 04/2001
2	Complement System Proteins (Complement)IBA 12/2019 - 01/2017
2	Dentifrices (Dentifrice)IBA 01/2017 - 01/2004
2	pro-brain natriuretic peptide (1-76)IBA 10/2008 - 10/2001
2	DiureticsIBA 08/2003 - 07/2002
2	Cyclin D1IBA 09/2001 - 05/2001
2	AntigensIBA 06/2001 - 05/2001
2	Messenger RNA (mRNA)IBA 04/2001 - 04/2001
2	Pain-FreeIBA 11/2000 - 11/2000
2	Sumatriptan (Imigran)FDA LinkGeneric 11/2000 - 11/2000
2	TabletsIBA 11/2000 - 11/2000
1	VenomsIBA 01/2021
1	Phospholipases A2 (Phospholipase A2)IBA 01/2021
1	Cytotoxins (Cytolysins)IBA 01/2021
1	DNA (Deoxyribonucleic Acid)IBA 09/2020
1	MethyltransferasesIBA 09/2020
1	ombitasvirIBA 01/2018
1	paritaprevirIBA 01/2018
1	Ritonavir (Norvir)FDA Link 01/2018
1	insulin receptor-related receptor (IRR)IBA 07/2017
1	InterleukinsIBA 01/2017
1	PotassiumIBA 01/2017
1	CytokinesIBA 01/2017
1	FluoridesIBA 01/2017
1	potassium nitrate (saltpeter)IBA 01/2017
1	Maleic Anhydrides (Maleic Anhydride)IBA 01/2017
1	AlbuminsIBA 10/2013
1	Urea (Carbamide)FDA LinkGeneric 10/2013
1	PlatinumIBA 02/2013
1	Glucose (Dextrose)FDA LinkGeneric 01/2013
1	Metformin (Glucophage)FDA LinkGeneric 01/2013
1	AcidsIBA 05/2011
1	S 27IBA 05/2011

Therapy/Procedure

4	Therapeutics 04/2016 - 04/2001
2	Critical Care (Surgical Intensive Care) 01/2021 - 04/2008
2	Resuscitation 01/2007 - 01/2007
2	Gamma Cameras (Gamma Camera) 06/2001 - 05/2001
1	Operative Surgical Procedures 11/2021
1	Synchrotrons 12/2019
1	Mastectomy (Mammectomy) 12/2019
1	Pain Management 01/2019
1	Splenectomy 01/2017
1	Therapeutic Embolization 01/2017
1	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 01/2014
1	Colostomy 03/2011
1	Pessaries 03/2011